Back to Search
Start Over
PL03.09 IMpower010:Overall Survival Interim Analysis of a Phase III Study of Atezolizumab vs Best Supportive Care in Resected NSCLC
- Source :
- Journal of Thoracic Oncology. 17:S2
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
- Subjects :
- Pulmonary and Respiratory Medicine
Oncology
Subjects
Details
- ISSN :
- 15560864
- Volume :
- 17
- Database :
- OpenAIRE
- Journal :
- Journal of Thoracic Oncology
- Accession number :
- edsair.doi...........8573b85597e2ee07916cfea08237f9ee
- Full Text :
- https://doi.org/10.1016/j.jtho.2022.07.013